Supernus Pharmaceuticals Competitors and Similar CompaniesClear all

Supernus Pharmaceuticals's competitors and similar companies include Neuraxpharm, moksha8 Pharmaceuticals and Intra-Cellular Therapies.

	Supernus Pharmaceuticals Supernus Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system disorders.	Neuraxpharm Neuraxpharm is a pharmaceutical company focusing on the treatment of central nervous system (CNS) disorders.	moksha8 Pharmaceuticals Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders.	Intra-Cellular Therapies Intra-Cellular Therapies develops drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the CNS.
Founding Date	Founding Date 2005	Founding Date 1985	Founding Date 2006	Founding Date 2002
Type	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare biotech drug development mental health pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech mental health pharma therapy	Tags Healthcare biotech drug development medical devices
Locations	Locations Rockville, US HQ	Locations Langenfeld (Rheinland), DE HQ Gießhübl, AT Hradec Králové, CZ Paris, FR Budapest, HU Dublin, IE Ascoli Piceno, IT see more	Locations Berwyn, US HQ Ciudad De México, MX	Locations New York, US HQ
Employees	Employees 6527% increase	Employees 8302% increase	Employees 3702% decrease	Employees 330352% increase
Valuation ($)	Valuation ($) 1.9 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 8.1 b
Financial
Revenue (est.)	Revenue (est.) $661.8m (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $680.9m (FY, 2024)
Net income	Net income $73.9m (FY, 2024)	Net income N/A	Net income N/A	Net income ($74.7m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 69.5m	Total funding raised N/A	Total funding raised $ 224.1m	Total funding raised $ 225.3m